Clinical Trials Directory

Trials / Completed

CompletedNCT05503758

Biomechanical Properties of the Lumbar Paravertebral Muscles

Quantification of Different Lumbar Paravertebral Muscles Properties in Women Who Experienced Cesarean Delivery Under Different Types of Anaesthesia

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
South Valley University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers

Summary

Cesarean delivery (CD) is an obstetric surgery for fetal delivery that involves both an abdominal incision (laparotomy) and a uterine incision (hysterotomy). It is presently the most prevalent surgery in the United States, with over 1 million women giving birth by cesarean section each year.

Detailed description

The anaesthetic types of choice for cesarean delivery are neuraxial and general anaesthesia. Neuraxial anesthesia is the gold standard anaesthesia for CD; it includes spinal and epidural anaesthesia. For spinal anaesthesia, local anesthetics are injected into the spinal canal, while for epidural anaesthesia, they are injected into the epidural space. Despite the superiority of neuraxial anaesthesia for cesarean delivery, general anesthesia is still performed to some extent especially when neuraxial anaesthesia is failed or inconsistent. General anesthesia involves a transient state of unconsciousness through the administration of inhaled anesthetic gases combined with intravenous drugs. LBP patients showed changes in their neuromuscular activity, reduction in the lumbar muscle flexibility, and alteration of the biomechanical properties of the lumbar muscles.

Conditions

Interventions

TypeNameDescription
DEVICEMyoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs).

Timeline

Start date
2021-06-28
Primary completion
2022-01-29
Completion
2022-01-29
First posted
2022-08-17
Last updated
2025-10-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05503758. Inclusion in this directory is not an endorsement.